Surgical treatment for hepatocellular carcinoma in elderly patients

Aging Health

Volumn 5, Issue 3, 2009, Pages 333-343

  Kondo, Kazuhiro ^a   Chijiiwa, Kazuo ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Elderly; Hepatocellular carcinoma; Morbidity; Mortality; Postoperative survival; Surgery

Indexed keywords

ABDOMINAL BLEEDING; AGED; ARTERY THROMBOSIS; ASCITES; BILE LEAKAGE; CANCER CLASSIFICATION; CANCER STAGING; COLITIS; DELIRIUM; ELDERLY CARE; GASTROINTESTINAL HEMORRHAGE; GERIATRIC PATIENT; HEPATIC ENCEPHALOPATHY; HUMAN; ILEUS; KIDNEY DYSFUNCTION; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER FUNCTION TEST; MORBIDITY; PATIENT SELECTION; PLEURA EFFUSION; PNEUMONIA; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; REVIEW; SEPSIS; SURGICAL APPROACH; SURGICAL INFECTION; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 70249089078     PISSN: 1745509X     EISSN: 17455103     Source Type: Journal    
DOI: 10.2217/ahe.09.20     Document Type: Review

References (73)

1. Yeung YP, Lo CM, Liu CL, Wong BC, Fan ST, Wong J: Natural history of untreated nonsurgical hepatocellular carcinoma. Am. J. Gastroenterol. 100, 1995-2004 (2005).
2. Huang YH, Chen CH, Chang TT et al.: The role of transcatheter arterial embolization in patients with resectable hepatocellular carcinoma: a nation-wide, multicenter study. Liver Int. 24, 419-424 (2004).
3. Shiina S, Teratani T, Obi S et al.: A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129, 122-130 (2005).
4. Takayasu K, Arii S, Ikai I et al.: Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 131, 461-469 (2006).
5. Todo S, Furukawa H, Tada M et al.: Extending indication: role of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl. 13, S48-S54 (2007).
6. Chapman WC, Doyle MBM, Stuart JE et al.: Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation. Ann. Surg. 248, 617-625 (2008).
7. Ravaioli M, Grazi GL, Piscaglia F et al.: Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria. Am. J. Transplant. 8, 2547-2557 (2008)
8. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Liver Cancer Study Group of Japan. Ann. Surg. 211(3), 277-287 (1990).
9. Ikai I, Yamaoka Y, Yamamoto Y et al.: Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy. Ann. Surg. 227, 433-439 (1998).
10. Ikenaga N, Chijiiwa K, Otani K et al.: Clinicopathologic characteristics of hepatocellular carcinoma with bile duct invasion. J. Gastrointest. Surg. 13(3), 492-497 (2009).
11. Chen MS, Li JQ, Zheng Y et al.: A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann. Surg. 243, 321-328 (2006).
12. Llovet JM, Real MI, Montaña et al.: Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled rrial. Lancet 359, 1734-1739 (2002).
13. Imamura H, Seyama Y, Kokudo N et al.: One thousand fifty-six hepatectomies without mortality in 8 years. Arch. Surg. 138, 1198-1206 (2003).
14. Hasegawa K, Kokudo N, Imamura H et al.: Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann. Surg. 242, 252-259 (2005).
15. Eguchi S, Kanematsu T, Arii S et al.: Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery 143, 469-475 (2008).
16. Kiyosawa K, Umemura T, Ichijo T et al.: Hepatocellular carcinoma: recent trends in Japan. Gastroenterology 127, S17-S26 (2004).
17. Bosetti C, Levi F, Boffetta P, Lucchini F, Negri E, La Vecchia C: Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. Hepatology 48, 137-145 (2008).
18. Chang MH, Chen CJ, Lai MS et al.: Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N. Engl. J. Med. 336, 1855-1859 (1997).
19. Oishi K, Itamoto T, Kobayashi T et al.: Hepatectomy for hepatocellular carcinoma in elderly patients aged 75 years or more. J. Gastrointest. Surg. DOI: 10.1007/s11605-008-0758-6 (2008).
20. Kondo K, Chijiiwa K, Funagayama M, Kai M, Otani K, Ohuchida J: Hepatic resection is justified for elderly patients with hepatocellular carcinoma. World J. Surg. 32, 2223-2229 (2008).
21. Nishiyama T, Fujimoto T, Hanaoka K: A comparison of liver function after hepatectomy in cirrhotic patients between sevoflurane and isoflurane in anesthesia with nitrous oxide and epidural block. Anesth. Analg. 98, 990-993 (2004).
22. Marchesini G, Bua V, Brunori A et al.: Galactose elimination capacity and liver volume in aging man. Hepatology 8, 1079-1083 (1988).
23. Wakabayashi H, Nishiyama Y, Ushiyama T, Maeba T, Maeta H: Evaluation of the effect of age on functioning hepatocyte mass and liver blood flow using liver scintigraphy in preoperative estimations for surgical patients: comparison with CT volumetry. J. Surg. Res. 106, 246-253 (2002).
24. Sastre J, Pallardó FV, Plá R et al.: Aging of the liver: age-associated mitochondrial damage in intact hepatocytes. Hepatology 24, 1199-1205 (1996)
25. Thomas RP, Guigneaux M, Wood T, Evers BM: Age-associated changes in gene expression patterns in the liver. J. Gastrointest. Surg. 6, 445-453 (2002).
26. Schmucker DL: Age-related changes in liver structure and function: implications for disease? Exp. Gerontol. 48, 650-659 (2005).
27. Brouwer A, Barelds RJ, Knook DL: Age-related changes in the endocytic capacity of rat liver Kupffer and endothelial cells. Hepatology 5, 362-366 (1985).
28. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R: Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 60, 646-649 (1973).
29. Takasaki T, Kobayashi S, Suzuki S et al.: Predetermining postoperative hepatic function for hepatectomies. Int. Surg. 65, 309-313 (1980).
30. Liver cancer study group of Japan: General rules for the clinical and pathological study of primary liver cancer (2nd English Edition). Kanehara Press, Tokyo, Japan (2003).
31. Kwon AH, Matsui Y, Ha-Kawa SK, Kamiyama Y: Functional hepatic volume measured by technetium-99m-galactosyl-human scrum albumin liver scintigraphy: comparison between hepatocyte volume and liver volume by computed tomography. Am. J. Gastroenterol. 96, 541-546 (2001).
32. Kwon AH, Matsui Y, Kaibori M, Ha-Kawa SK: Preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin (GSA-Rmax) is useful for judging the safety of hepatic resection. Surgery 140, 379-386 (2006).
33. Okamoto E, Kyo A, Yamanaka N, Tanaka N, Kuwata K: Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery 95, 586-592 (1984).
34. Richardson JD, Cocanour CS, Kern JA et al.: Perioperative risk assessment in elderly and high-risk patients. J. Am. Coll. Surg. 199, 133-146 (2004).
35. Kudo M, Chung H, Haji S et al.: Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score. Hepatology 40. 1396-1405 (2004).
36. Kondo K, Chijiiwa K, Nagano M, et al.: Comparison of seven prognostic staging systems in patients who undergo hepatectomy for hepatocellular carcinoma. Hepatogastroenterology 54, 1534-1538 (2007).
37. A new prognostic system for hepatocellular carcinoma: a retrospective study of 453 patients: the Cancer of the Liver Italian program (CLIP) investigators. Hepatology 28, 751-755 (1998).
38. Shafritz DA, Shouval D, Sherman HI, Hadziyannis SJ, Kew MC: Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. N. Engl. J. Med. 305, 1067-1073 (1981).
39. Tong MJ, el-Farra NS, Reikes AR, Co RL: Clinical outcomes after transfusion-associated hepatitis C. N. Engl. J. Med. 332, 1463-1466 (1995).
40. Kondo K, Chijiiwa K, Funagayama M, Kai M, Otani K, Ohuchida J: Differences in long-term outcome and prognostic factors according to viral status in patients with hepatocellular carcinoma treated by surgery. J. Gastrointest. Surg. 12, 468-476 (2008).
41. Ezaki T, Yukaya H, Ogawa Y: Evaluation of hepatic resection for hepatocellular carcinoma in the elderly. Br. J. Surg. 74, 471-473 (1987).
42. Yanaga K, Kanematsu T, Takenaka K, Matsumata T, Yoshida Y, Sugimachi K: Hepatic resection for hepatocellular carcinoma in elderly patients. Am. J. Surg. 155, 238-241 (1988).
43. Chen MF, Hwang TL, Jeng LB, Jan YY, Wang CS: Influence of age on results of resection of hepatocellular carcinoma. Eur. J. Surg. 157, 591-593 (1991).
44. Nagasue N, Chang YC, Takemoto Y, Taniura H, Kohno H, Nakamura T: Liver resection in the aged (seventy years or older) with hepatocellular carcinoma. Surgery 113, 148-154 (1993).
45. Takenaka K, Shimada M, Higashi H et al.: Liver resection for hepatocellular carcinoma in the elderly. Arch. Surg. 129, 846-850 (1994).
46. Ou LH, Chau GY, Tsay SH et al.: Clinicopathological comparison of resectable hepatocellular carcinoma between the young and the elderly patients. Zhonghua Yi Xue Za Zhi (Taipei) 60, 40-47 (1997).
47. Yamamoto K, Takenaka K, Matsumata T et al.: Right hepatic lobectomy in elderly patients with hepatocellular carcinoma. Hepatogastroenterology 44, 514-518 (1997).
48. Poon RT, Fan ST, Lo CM et al.: Hepatocelluiar carcinoma in the elderly: results of surgical and nonsurgical management. Am. J. Gastroenterol. 94, 2460-2466 (1999).
49. Wu CC, Chen JT, Ho WL et al.: Liver resection for hepatocellular carcinoma in octogenarians. Surgery 125, 332-338 (1999).
50. Lui WY, Chau GY, Wu CW, King KL: Surgical resection of hepatocellular carcinoma in elderly cirrhotic patients. Hepatogastroenterology 46, 640-645 (1999).
51. Hanazaki K, Kajikawa S, Shimozawa N et al.: Hepatic resection for hepatocellular carcinoma in the elderly. J. Am. Coll. Surg. 192, 38-46 (2001).
52. Mercantini P, Corigliano N, Lucandri G et al.: Surgical treatment of hepatocellular carcinoma in elderly cirrhotic patients: personal experience. Anticancer Res. 22, 3709-3712 (2002).
53. Yeh CN, Lee WC, Jeng LB, Chen MF: Hepatic resection for hepatocellular carcinoma in elderly patients. Hepatogastroenterology 51, 219-223 (2004).
54. Ferrero A, Vigano L, Polastri R et al.: Hepatectomy as treatment of choice for hepatocellular carcinoma in elderly cirrhotic patients. World J. Surg. 29, 1101-1105 (2005).
55. Zhou L, Rui JA, Wang SB et al.: Clinicopathological features, post-surgical survival and prognostic indicators of elderly patients with hepatocellular carcinoma. Eur. J. Surg. Oncol. 32, 762-772 (2006).
56. Kaibori M, Matsui K, Ishizaki M et al.: Hepatic resection for hepatocellular carcinoma in the elderly. J. Surg. Oncol. 99, 154-160 (2009).
57. Tsukioka G, Kakizaki S, Sohara N et al.: Hepatocellular carcinoma in extremely elderly patients: an analysis of clinical characteristics, prognosis and patient survival. World J. Gastroenterol. 12, 48-53 (2006).
58. Pringle JH: V. Notes on the arrest of hepatic hemorrhage due to trauma. Ann. Surg. 48, 541-549 (1908).
59. Makuuchi M, Mori T, Gunvén P, Yamazaki S, Hasegawa H: Safety of hemihepatic vascular occlusion during resection of the liver. Surg. Gynecol. Obstet. 164, 455-158 (1987).
60. Otsubo T, Takasaki K, Yamamoto M et al.: Bleeding during hepatectomy can be reduced by clamping the inferior vena cava below the liver. Surgery 135, 67-73 (2004).
61. Belghiti J, Guevara OA, Noun R, Saldinger PF, Kianmanesh R: Liver hanging maneuver: a safe approach to right hepatectomy without liver mobilization. J. Am. Coll. Surg. 193, 714-716 (2001).
62. Tranberg KG, Rigotti P, Bracket KA, Bjornson HS, Fischer JE, Joffe SN: Liver resection. A comparison using the Nd-YAG laser, an ultrasonic surgical aspirator, or blunt dissection. Am. J. Surg. 151, 368-373 (1986).
63. Sakamoto Y, Yamamoto J, Kokudo N et al.: Bloodless liver resection using the monopolar floating ball plus ligasure diathermy: preliminary results of 16 liver resections. World J. Surg. 28, 166-172 (2004).
64. Sasaki A, Nitta H, Otsuka K, Takahara T, Nishizuka S, Wakabayashi G: Ten-year experience of totally laparoscopic liver resection in a single institution. Br. J. Surg. 96, 274-279 (2009).
65. Hamel MB, Henderson WG, Khuri SF, Daley J: Surgical outcomes for patients aged 80 and older: morbidity and mortality from major noncardiac surgery J. Am. Geriatr. Soc. 53, 424-429 (2005).
66. Berger DH, Dardik A, Rosenthal RA: Surgery in the elderly. In: Sabiston Textbook of Surgery (18th Edition). Townsend Jr CM, Beauchamp RD, Evers BM, Mattox KL (Eds). Saunders Elsevier, PA, USA 371-398 (2008).
67. Aldrighetti L, Arru M, Catena M, Finazzi R, Ferla G: Liver resections in over-75-year-old patients: surgical hazard or current practice? J. Surg. Oncol. 93, 186-193 (2006).
68. Clavien PA, Sanabria JR, Strasberg SM: Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery 111, 518-526 (1992).
69. Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg. 240, 205-213 (2004).
70. van Dam RM, Hendry PO, Coolsen MM et al.: Initial experience with a multimodal enhanced recovery programme in patients undergoing liver resection. Br. J. Surg. 95, 969-975 (2008).
71. Ershler WB: Why tumors grow more slowly in old people. J. Natl Cancer Inst. 77, 837-839 (1986).
72. Dripps RD, Lament A, Eckenhoff JE: The role of anesthesia in surgical mortality. JAMA 178, 261-266 (1961).
73. Kitagawa T, Hara M, Sano T, Sugimura T: The concept of Tenju-gann, or 'natural-end cancer'. Cancer 83, 1061-1065 (1998).